Transcranial magnetic stimulation for migraine: Clinical effects

被引:81
作者
Clarke B.M. [1 ,2 ]
Upton A.R.M. [1 ]
Kamath M.V. [1 ]
Al-Harbi T. [1 ]
Castellanos C.M. [1 ]
机构
[1] Division of Neurology, McMaster University, Hamilton, ON L8N 3Z5
[2] Hamilton Health Sciences Centre, Department of Clinical Neurology, McMaster University, Hamilton, ON L8N 3Z5
基金
加拿大自然科学与工程研究理事会;
关键词
Migraine; Pain; Transcranial magnetic stimulation;
D O I
10.1007/s10194-006-0329-8
中图分类号
学科分类号
摘要
The objective was to assess the impact of transcranial magnetic stimulation (TMS) on pain and the autonomic nervous system (ANS) in migraine. Fortytwo people [mean age 41.43 ± 11.69 (SD) years, 36 females] were randomised into high vs. low TMS stimulation groups and received 2 brief pulses of TMS. Thirty-three (33/42) individuals had heart-rate variability assessed, before and after stimulation. No group effects were found. Pain decreased by 75%; 32% of people after 1 treatment reported no headache after 24 h. Mean heart rate decreased from 79.05 ± 10.27 to 72.89 ± 11.35 beats/min. The low-frequency (LF) and the high-frequency (HF) areas derived from power spectral analyses increased [mean 6522 ± 1277 to 8315 ± 1009 beats/min2 (LF) (p=0.001) and mean 5600 ± 1568 to 8755 ± 3071 beats/min2 (HF) (p=0.001)]. The LF:HF ratio decreased from mean 1.31 ± 0.51 to 1.13 ± 0.48 (NS). TMS produces immediate, sustained reductions in pain and modification of the ANS. © Springer-Verlag Italia 2006.
引用
收藏
页码:341 / 346
页数:5
相关论文
共 42 条
[31]  
Gursoy-Ozdemir Y., Qiu J., Matsuoka N., Et al., Cortical spreading depression activates and upregulates MMP-9, J Clin Invest, 113, pp. 1447-1455, (2004)
[32]  
Spierings E.L., Symptomatology and pathogenesis of migraine, J Pediatr Gastroenterol Nutr, 21, SUPPL. 1, (1995)
[33]  
Boccuni M., Alessandri M., Fusco B.M., Cangi F., The pressor hyperresponsiveness to phenylephrine unmasks sympathetic hypofunction in migraine, Cephalalgia, 9, pp. 239-245, (1989)
[34]  
Haeter K., Ayata C., Moskowitz M.A., Cortical spreading depression: A model for understanding migraine biology and future drug targets, Headache Curr, 2, pp. 97-103, (2005)
[35]  
Wassermann E.M., Risk and safety of repetitive transcranial magnetic stimulation: Report and suggested guidelines from the International Workshop on Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996, Electroencephalogr Clin Neurophysiol, 108, pp. 1-16, (1998)
[36]  
Anand S., Hotson J., Transcranial magnetic stimulation: Neurophysiological applications and safety, Brain Cogn, 50, pp. 366-386, (2002)
[37]  
The International Classification of Headache Disorders, Cephalalgia, 14, SUPPL. 1, pp. 8-152, (2004)
[38]  
Clarke B.M., Upton A.R.M., Castellanos C.M., Schmuck M.L., Measuring and assessing suffering in arthritic patients, Spirituality and Health: Multidisciplinary Explorations, pp. 227-240, (2005)
[39]  
Heart Rate Variability, (1995)
[40]  
Appel S., Kuritzky A., Zahavi I., Et al., Evidence for instability of the autonomic nervous-system in patients with migraine headache, Headache, 32, pp. 10-17, (1992)